Contact

The FAMHP has moved: from 1 March 2021, you will be able to find our departments at the following address.

Federal Agency for Medicines and Health Products - FAMHP
Avenue Galilée 5/03
1210 BRUSSELS

Map: PNG - PDF

Google Maps

QR CODE AFMPS - FAGG - FAAG - FAMHP

All our telephone numbers and e-mail addresses remain the same.

+32 2 528 40 00 (from 8 AM to 4 PM on working days)
welcome@fagg-afmps.be

EORI number BE0884579424

Send your questions to the FAMHP by e-mail.
If you don’t know which is the appropriate department send it simply to the general e-mail address at FAMHP: welcome@fagg-afmps.be. Your question will then be passed on to the relevant department.

 

Authorisations and certificates

Billingpurchases@fagg-afmps.be

Borderline products whose status is unclear - borderline.hum@fagg-afmps.be - borderline.vet@fagg-afmps.be

Chief Executive Officer, Xavier De Cuyper - management@fagg-afmps.be (Secretariat)

Complaints - Complaints about the FAMHP?

Herbal Medicines - phyto@fagg-afmps.be

Homeopathic medicines - homeo@fagg-afmps.be

Human body material (MCH-MLM) - mch-mlm@fagg-afmps.be

Information on the proper use of medicines and health products - info.medicines@fagg-afmps.be

Inspection and control – General - inspection@fagg-afmps.be

Inspection and control – Pharmacies - pharmacy@fagg-afmps.be

Inspection and control – Distribution of medicines - distribution@fagg-afmps.be

Inspection and control – Industry - industry@fagg-afmps.be

Inspection and control - Medical devices - inspection.meddev@fagg-afmps.be

Inspection and control – Special Investigation Unit - medicrime@fagg-afmps.be

Inspection and control - Pharmacovigilance - phvinsp@fagg-afmps.be

Inspection and control - Publicity - General - publicity@fagg-afmps.be

Inspection and control - Human Body Material -  inspection.hbm@fagg-afmps.be

Legal Affairs - ius@fagg-afmps.be

Marketing Authorisation - Variations and Renewals - postlicensing@fagg-afmps.be

Medicines for veterinary use - infovet@fagg-afmps.be

National Innovation Office - innovationoffice@fagg-afmps.be

Narcotics and psychotropics - narcotics@fagg-afmps.be

Precursors - drugprecursor@fagg-afmps.be

Press (For journalists only) - comm@fagg-afmps.be
Ann Eeckhout, spokesperson of the FAMHP
phone +32 2 528 40 12
mobile +32 495 23 71 69

Publicity – Notification and visum - advertising@fagg-afmps.be

Research and Development (R&D) - ct.rd@fagg-afmps.be

Scientific-Technical Advice (STA) - sta@fagg-afmps.be

Supply problems and commercialisations - supply-problems@fagg-afmps.be

Vigilance of medicines for human use - vig@fagg-afmps.be

Webmaster - webmaster@fagg-afmps.be

Medical devices

All current e-mail addresses dedicated to the medical devices and in-vitro diagnostics (IVDs) will be reorganised in order to ensure a better management of the incoming emails and to increase efficiency in processing them.

From the 15th of March 2021, the following e-mail addresses will be phased out and eventually disappear completely:

• meddev@fagg-afmps.be
• IVD@fagg-afmps.be
• ALCL@fagg-afmps.be
• notifications@fagg-afmps.be
• contributions@fagg-afmps.be

These general e-mail addresses will be replaced by more specific ones. All new e-mail addresses will be used for enquiries related to medical devices and medical devices for in-vitro diagnostics (IVDs).

For all enquiries about the following topics Contact
- Clinical investigations
- Performance studies
- Serious adverse events
CT.RD@fagg-afmps.be
- Scientific-technical advice on innovative devices
- Requests for advice from a Notified Body (Transmissible Spongiform Encephalopathies (TSE)...)
STA.meddev@fagg-afmps.be
- Notified Bodies and Notified Body certificates (withdrawal, suspension ...)
- Questions related to Notified Bodies
NB.meddev@fagg-afmps.be
Applications for certificates of free sale and questions related to those certificates FSC.meddev@fagg-afmps.be
- Compassionate use
- Derogations
- Appeals
derogation.meddev@fagg-afmps.be
All vigilance related documents and questions:
- (serious) incident
- Manufacturer Incident Report (MIR)
- Periodic Summary Report (PSR)
- Field Safety Corrective Action (FSCA)
- Field Safety Notice (FSN)
- Trend report
- Post Market Surveillance (PMS) report
- Periodic Safety Update Report (PSUR) + evaluation
- Breast Implant Associated – Anaplastic Large Cell Lymphoma (BIA-ALCL)
- All security and safety issues with devices
vigilance.meddev@fagg-afmps.be
Central traceability register RCT-CTR.meddev@fagg-afmps.be
- Inspection related files
- Advertising and promotion of medical devices
- Self-checking guide (Good distribution practices)
- My control/Self-checking form section on the Portal
- Violations of the medical devices and IVD legislations by registered actors
inspection.meddev@fagg-afmps.be
- Fraud
- Prosecution files
- Violations of the medical device and IVD legislations by non-registered actors
medicrime@fagg-afmps.be
- Marketing and distribution notifications
- Registration of actors
- Business questions related to online applications (except the Autocontrol application)
- Registration in EUDAMED
notifications.meddev@fagg-afmps.be
All technical questions regarding the online applications and the web portal (except EUDAMED) support.portal@fagg-afmps.be
Technical issues with EUDAMED SANTE-EUDAMED-SUPPORT@ec.europa.eu
Contributions Contributions.meddev@fagg-afmps.be
The implementation of Regulations (EU) 2017/745 and (EU) 2017/746 Recast.meddev@fagg-afmps.be
- Qualification
- Classification
- Invitations for European/national meetings
- All other enquiries that are not related to topics of the other email boxes
Info.meddev@fagg-afmps.be
All enquiries about SARS-CoV-2 antigen tests Antigen@fagg-afmps.be
All enquiries about SARS-CoV-2 serological tests Serology@fagg-afmps.be

 

Last updated on 14/10/2021